Genomic signatures of the haarlem lineage of Mycobacterium tuberculosis: implications of strain genetic variation in drug and vaccine development.

Journal of Clinical Microbiology
Andrés Cubillos-RuizPatricia del Portillo

Abstract

Tuberculosis is the world's leading cause of death due to a single infectious agent, and efforts aimed at its control require a better understanding of host, environmental, and bacterial factors that govern disease outcome. Growing evidence indicates that certain Mycobacterium tuberculosis strains of distinct phylogeographic lineages elicit unique immunopathological events. However, identifying the genetic basis of these phenotypic peculiarities has proven difficult. Here we report the presence of six large sequence polymorphisms which, together with two single-nucleotide changes previously described by our group, consistently differentiate Haarlem strains from the remaining M. tuberculosis lineages. The six newly found Haarlem-specific genetic events are four deletions, which altogether involve more than 13 kb, and two intragenic insertions of the element IS6110. The absence of the genes involved in these polymorphisms could have an important physiological impact on Haarlem strains, i.e., by affecting key genes, such as Rv1354c and cyp121, which have been recently proposed as plausible drug targets. These lineage-specific polymorphisms can serve as genetic markers for the rapid PCR identification of Haarlem strains, providing ...Continue Reading

References

Sep 18, 1997·The Journal of Infectious Diseases·V RitaccoI N de Kantor
Jan 28, 1999·Methods in Molecular Biology·H F HeersmaJ D van Embden
May 1, 1999·Biochemical and Biophysical Research Communications·L RindiC Garzelli
Mar 1, 2000·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S L SampsonP D van Helden
Sep 12, 2003·Emerging Infectious Diseases·Domingo PalmeroEduardo Abbate
Mar 17, 2004·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Véronique DuchêneChristophe Sola
Mar 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anthony G TsolakiPeter M Small
Nov 5, 2004·Molecular Biology of the Cell·Kwasi G MawuenyegaXian Chen
Feb 19, 2005·Nucleic Acids Research·Deo Prakash Pandey, Kenn Gerdes
Mar 16, 2005·The Lancet Infectious Diseases·Aeesha N J Malik, Peter Godfrey-Faussett
Jul 5, 2005·Trends in Microbiology·Vickery L ArcusSusan J Turner
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sebastien GagneuxPeter M Small
Sep 26, 2006·Journal of Bacteriology·Xiaoming LiuYun-Xin Fu
Oct 17, 2006·Clinical Microbiology Reviews·Barun MathemaBarry N Kreiswirth
Apr 24, 2007·The Lancet Infectious Diseases·Sebastien Gagneux, Peter M Small
Jul 14, 2007·Tuberculosis·Christopher R E McEvoyRobin M Warren
Sep 14, 2007·Immunological Reviews·William R Berrington, Thomas R Hawn
Nov 11, 2008·BMC Research Notes·Andrés Cubillos-RuizMaría Mercedes Zambrano
Dec 6, 2008·Environmental Health Perspectives·Charles W Schmidt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.